Wuhan ZhongYou Pharmaceutical Co., Ltd
Add： 28 chuangye avenue, gedian development zone
- Time of issue:2018-01-08 00:00:00
Wuhan ZY Pharmaceutical Co., Ltd was established in April 2009, locates in Gedian economic and technological development zone, E-Zhou, Hubei province, and is the modernized API manufacturer complying with FDA cGMP standard, and also focuses on generic drugs research and development. There are two phases for the construction of our factory, and the phase I covers 115,000 ㎡， and Phase II covers around 133,340 ㎡， total area 247,752㎡。 The Phase I was completed in Dec.2013 with trial production in April, 2013, has pilot workshop for pharmaceutical API, multi-function workshop, synthesis workshop of vertical flow, hydrogenation workshop and auxiliary projects, such as boiler plant, engineering building, sewage treatment station. We obtained Pharmaceutical producer license from SFDA in Oct.2013, and obtained GMP （2010） of Atorvastatin Calcium & Fasudil Mesylate later. We have nearly 130 staffs now, there will be more than 300 employees after the construction of Phase II.
Wuhan ZY pharmaceutical has a team of high-talent people from home and abroad to strengthen the R&D capability, aiming to build a vertical system from R&D to pilot product and commercial production. The production area and laboratories are well equipped with state-of-the-art facilities and equipment including analytical devices, water system and air compressing system as well as automatic waste treatment and online environment monitoring systems. The plant is designed and constructed according to ISO, OSHA, and EHS principles, and fully complies with EU GMP and FDA requirements. Our products have already been exported to the US, Europe and India, and we are expecting the inspection from EU authority and FDA respectively in the coming year.
Till now, we have completed several projects of innovative API technology in the cardiovascular, digestion, antifungal and anti-virus field. In the forthcoming 3-5 years, we are expecting to complete 20-24 generic API developments. Those products will be for internal FDF use as well as for external markets where EDMF, USDMF and CEP will be filed according to the regulatory requirements.
Scan the QR code to read on your phone
Mobile web site